Pasquali et al. [14] hypothesized that the loss of ERβ may promote cell proliferation and, possibly, carcinogenesis by some unknown mechanism based on the loss of ERβ expression in prostate hyperplasia and carcinoma. Here, ESR2 is linked to benign prostatic hyperplasia.